Home > PE Ratio > FREDUN PHARMACEUTICALS

FREDUN PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of FREDUN PHARMACEUTICALS is 26.82.

Share Price ₹824.8Apr 24,2024
Market Cap ₹387.6 Cr
Earnings-TTM₹14.5 CrTTM-Standalone Results
Price/Earnings26.82xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for FREDUN PHARMACEUTICALS
Please provide your vote to see the results
FREDUN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of FREDUN PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of FREDUN PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹387.6 Cr] as on Apr 24,2024

(/) Earnings [ ₹14.5 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 26.82x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for FREDUN PHARMACEUTICALS , the investors are currently willing to pay 26.82 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of FREDUN PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of FREDUN PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of FREDUN PHARMACEUTICALS


PE Ratio Performance Analysis for FREDUN PHARMACEUTICALS

- FREDUN PHARMACEUTICALS 's latest p/e ratio is 26.82x.

- FREDUN PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 50.15x.

- FREDUN PHARMACEUTICALS 's operated at median p/e ratio of 37.85x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, FREDUN PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 91.79x.

- FREDUN PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 24.45x.


How does FREDUN PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
FREDUN PHARMACEUTICALS 14.4526.82387.6
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6339.63356,625.0
CIPLA LTD3,744.0330.16112,938.0
DR REDDYS LABORATORIES LTD5,209.4019.0699,276.9
ZYDUS LIFESCIENCES LTD2,954.2031.7993,921.9
DIVIS LABORATORIES LTD1,382.9773.26101,315.0
MANKIND PHARMA LTD1,743.3055.1596,143.2
TORRENT PHARMACEUTICALS LTD1,494.0060.8390,872.6
LUPIN LTD1,809.7439.7972,010.8
AUROBINDO PHARMA LTD2,777.8922.8663,492.3
ABBOTT INDIA LTD1,145.5847.2354,105.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs FREDUN PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.06x
Max industry PE 73.26x
Median industry PE 39.63x
Average industry PE 40.60x



You may also like the below Video Courses